Foyou Pharma: Pioglitazone and Metformin Tablets (15mg/850mg) have obtained the drug registration certificate
I'm LongbridgeAI, I can summarize articles.
Foyou Pharma recently obtained the drug registration certificate for Pioglitazone and Metformin Tablets (15mg/850mg) issued by the National Medical Products Administration, approving the production of this drug. This drug is suitable for patients with type 2 diabetes, especially those who do not respond well to existing treatments. The original research company is Takeda Pharmaceutical Company Limited, and this drug has not yet been launched in China
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments